The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostacyclin-Global Market Insights and Sales Trends 2025
Synopsis
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostacyclin market size is expected to reach US$ 3847.4 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Prostacyclin in various end use industries. The expanding demands from the For Injection, For Oral and For Inhalation,, are propelling Prostacyclin market. Epoprostenol Sodium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treprostinil segment is estimated at % CAGR for the next seven-year period.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostacyclin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostacyclin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostacyclin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostacyclin covered in this report include United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma and Bayer AG, etc.
The global Prostacyclin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Global Prostacyclin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostacyclin market, Segment by Type:
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Global Prostacyclin market, by Application
For Injection
For Oral
For Inhalation
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Prostacyclin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
The global Prostacyclin market size is expected to reach US$ 3847.4 million by 2029, growing at a CAGR of 7.1% from 2023 to 2029. The market is mainly driven by the significant applications of Prostacyclin in various end use industries. The expanding demands from the For Injection, For Oral and For Inhalation,, are propelling Prostacyclin market. Epoprostenol Sodium, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Treprostinil segment is estimated at % CAGR for the next seven-year period.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostacyclin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostacyclin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostacyclin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostacyclin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostacyclin covered in this report include United Therapeutics, Actelion (J & J), GSK, Teva, Toray, Tide Pharma and Bayer AG, etc.
The global Prostacyclin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Global Prostacyclin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostacyclin market, Segment by Type:
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Global Prostacyclin market, by Application
For Injection
For Oral
For Inhalation
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Prostacyclin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Prostacyclin Market Overview
1.1 Prostacyclin Product Overview
1.2 Prostacyclin Market Segment by Type
1.2.1 Epoprostenol Sodium
1.2.2 Treprostinil
1.2.3 Iloprost
1.2.4 Beraprost Sodium
1.3 Global Prostacyclin Market Size by Type
1.3.1 Global Prostacyclin Market Size Overview by Type (2018-2029)
1.3.2 Global Prostacyclin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Prostacyclin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Prostacyclin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Prostacyclin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Prostacyclin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Prostacyclin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Prostacyclin Sales Breakdown by Type (2018-2023)
2 Global Prostacyclin Market Competition by Company
2.1 Global Top Players by Prostacyclin Sales (2018-2023)
2.2 Global Top Players by Prostacyclin Revenue (2018-2023)
2.3 Global Top Players by Prostacyclin Price (2018-2023)
2.4 Global Top Manufacturers Prostacyclin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Prostacyclin Market Competitive Situation and Trends
2.5.1 Prostacyclin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Prostacyclin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostacyclin as of 2022)
2.7 Date of Key Manufacturers Enter into Prostacyclin Market
2.8 Key Manufacturers Prostacyclin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Prostacyclin Status and Outlook by Region
3.1 Global Prostacyclin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Prostacyclin Historic Market Size by Region
3.2.1 Global Prostacyclin Sales in Volume by Region (2018-2023)
3.2.2 Global Prostacyclin Sales in Value by Region (2018-2023)
3.2.3 Global Prostacyclin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Prostacyclin Forecasted Market Size by Region
3.3.1 Global Prostacyclin Sales in Volume by Region (2024-2029)
3.3.2 Global Prostacyclin Sales in Value by Region (2024-2029)
3.3.3 Global Prostacyclin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Prostacyclin by Application
4.1 Prostacyclin Market Segment by Application
4.1.1 For Injection
4.1.2 For Oral
4.1.3 For Inhalation
4.2 Global Prostacyclin Market Size by Application
4.2.1 Global Prostacyclin Market Size Overview by Application (2018-2029)
4.2.2 Global Prostacyclin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Prostacyclin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Prostacyclin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Prostacyclin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Prostacyclin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Prostacyclin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Prostacyclin Sales Breakdown by Application (2018-2023)
5 North America Prostacyclin by Country
5.1 North America Prostacyclin Historic Market Size by Country
5.1.1 North America Prostacyclin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Prostacyclin Sales in Volume by Country (2018-2023)
5.1.3 North America Prostacyclin Sales in Value by Country (2018-2023)
5.2 North America Prostacyclin Forecasted Market Size by Country
5.2.1 North America Prostacyclin Sales in Volume by Country (2024-2029)
5.2.2 North America Prostacyclin Sales in Value by Country (2024-2029)
6 Europe Prostacyclin by Country
6.1 Europe Prostacyclin Historic Market Size by Country
6.1.1 Europe Prostacyclin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Prostacyclin Sales in Volume by Country (2018-2023)
6.1.3 Europe Prostacyclin Sales in Value by Country (2018-2023)
6.2 Europe Prostacyclin Forecasted Market Size by Country
6.2.1 Europe Prostacyclin Sales in Volume by Country (2024-2029)
6.2.2 Europe Prostacyclin Sales in Value by Country (2024-2029)
7 Asia-Pacific Prostacyclin by Region
7.1 Asia-Pacific Prostacyclin Historic Market Size by Region
7.1.1 Asia-Pacific Prostacyclin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Prostacyclin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Prostacyclin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Prostacyclin Forecasted Market Size by Region
7.2.1 Asia-Pacific Prostacyclin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Prostacyclin Sales in Value by Region (2024-2029)
8 Latin America Prostacyclin by Country
8.1 Latin America Prostacyclin Historic Market Size by Country
8.1.1 Latin America Prostacyclin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Prostacyclin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Prostacyclin Sales in Value by Country (2018-2023)
8.2 Latin America Prostacyclin Forecasted Market Size by Country
8.2.1 Latin America Prostacyclin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Prostacyclin Sales in Value by Country (2024-2029)
9 Middle East and Africa Prostacyclin by Country
9.1 Middle East and Africa Prostacyclin Historic Market Size by Country
9.1.1 Middle East and Africa Prostacyclin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Prostacyclin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Prostacyclin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Prostacyclin Forecasted Market Size by Country
9.2.1 Middle East and Africa Prostacyclin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Prostacyclin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 United Therapeutics
10.1.1 United Therapeutics Company Information
10.1.2 United Therapeutics Introduction and Business Overview
10.1.3 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 United Therapeutics Prostacyclin Products Offered
10.1.5 United Therapeutics Recent Development
10.2 Actelion (J & J)
10.2.1 Actelion (J & J) Company Information
10.2.2 Actelion (J & J) Introduction and Business Overview
10.2.3 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Actelion (J & J) Prostacyclin Products Offered
10.2.5 Actelion (J & J) Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Prostacyclin Products Offered
10.3.5 GSK Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Teva Prostacyclin Products Offered
10.4.5 Teva Recent Development
10.5 Toray
10.5.1 Toray Company Information
10.5.2 Toray Introduction and Business Overview
10.5.3 Toray Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Toray Prostacyclin Products Offered
10.5.5 Toray Recent Development
10.6 Tide Pharma
10.6.1 Tide Pharma Company Information
10.6.2 Tide Pharma Introduction and Business Overview
10.6.3 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Tide Pharma Prostacyclin Products Offered
10.6.5 Tide Pharma Recent Development
10.7 Bayer AG
10.7.1 Bayer AG Company Information
10.7.2 Bayer AG Introduction and Business Overview
10.7.3 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Bayer AG Prostacyclin Products Offered
10.7.5 Bayer AG Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Prostacyclin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Prostacyclin Industrial Chain Analysis
11.4 Prostacyclin Market Dynamics
11.4.1 Prostacyclin Industry Trends
11.4.2 Prostacyclin Market Drivers
11.4.3 Prostacyclin Market Challenges
11.4.4 Prostacyclin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Prostacyclin Distributors
12.3 Prostacyclin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
